9.93
前日終値:
$9.35
開ける:
$9.45
24時間の取引高:
2.23M
Relative Volume:
0.88
時価総額:
$1.17B
収益:
$2.35B
当期純損益:
$-74.42M
株価収益率:
-10.56
EPS:
-0.94
ネットキャッシュフロー:
$150.93M
1週間 パフォーマンス:
+4.20%
1か月 パフォーマンス:
-7.28%
6か月 パフォーマンス:
-1.68%
1年 パフォーマンス:
-55.25%
Evolent Health Inc Stock (EVH) Company Profile
名前
Evolent Health Inc
セクター
電話
571-389-6000
住所
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
EVH を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
EVH
Evolent Health Inc
|
9.93 | 1.10B | 2.35B | -74.42M | 150.93M | -0.94 |
![]()
VEEV
Veeva Systems Inc
|
290.41 | 47.59B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
64.49 | 10.97B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
60.77 | 11.37B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
96.04 | 8.16B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.83 | 6.40B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-10 | 開始されました | Needham | Buy |
2024-12-03 | 繰り返されました | BTIG Research | Buy |
2024-11-08 | ダウングレード | Stephens | Overweight → Equal-Weight |
2024-10-11 | 開始されました | KeyBanc Capital Markets | Overweight |
2024-08-09 | アップグレード | Truist | Hold → Buy |
2024-04-22 | 開始されました | Citigroup | Buy |
2024-03-01 | 開始されました | Oppenheimer | Outperform |
2024-01-03 | 開始されました | Barclays | Overweight |
2023-12-06 | 開始されました | JMP Securities | Mkt Outperform |
2023-10-16 | 開始されました | UBS | Buy |
2023-04-12 | 開始されました | Stephens | Overweight |
2022-11-01 | 開始されました | Truist | Hold |
2022-07-29 | 開始されました | RBC Capital Mkts | Outperform |
2022-03-30 | 開始されました | Guggenheim | Buy |
2021-11-18 | アップグレード | JP Morgan | Neutral → Overweight |
2021-04-29 | 再開されました | JP Morgan | Neutral |
2021-01-07 | 開始されました | BTIG Research | Buy |
2020-07-06 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
2020-06-05 | ダウングレード | Goldman | Buy → Neutral |
2020-06-02 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
2018-10-05 | 再開されました | Leerink Partners | Outperform |
2018-06-04 | 開始されました | Piper Jaffray | Overweight |
2018-04-24 | 再開されました | JP Morgan | Neutral |
2017-09-20 | 開始されました | KeyBanc Capital Mkts | Overweight |
2017-06-02 | 開始されました | Robert W. Baird | Outperform |
2017-03-14 | 開始されました | Oppenheimer | Outperform |
2017-01-13 | アップグレード | Wells Fargo | Market Perform → Outperform |
2016-10-28 | 再開されました | JP Morgan | Overweight |
2016-08-05 | 繰り返されました | FBR Capital | Outperform |
2016-07-26 | 開始されました | Jefferies | Buy |
2016-07-13 | 繰り返されました | FBR Capital | Outperform |
2016-03-29 | 開始されました | FBR Capital | Outperform |
2016-01-06 | 開始されました | Canaccord Genuity | Buy |
2015-06-30 | 開始されました | Goldman | Buy |
2015-06-30 | 開始されました | JP Morgan | Overweight |
2015-06-30 | 開始されました | Leerink Partners | Outperform |
2015-06-30 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
すべてを表示
Evolent Health Inc (EVH) 最新ニュース
The Analyst Verdict: Evolent Health In The Eyes Of 5 Experts - 富途牛牛
What drives Evolent Health Inc. stock priceAccelerated investment success - PrintWeekIndia
What makes Evolent Health Inc. stock attractive to long term investorsMarket-crushing profits - jammulinksnews.com
Will Evolent Health Inc. stock split in the near futureOverwhelming profit margins - jammulinksnews.com
How Evolent Health Inc. stock reacts to Fed policy changesJaw-dropping returns - jammulinksnews.com
What analysts say about Evolent Health Inc. stockHigh-margin investment plays - Autocar Professional
Elevance Health, EchoStar, Icahn Enterprises, Evolent Health, and The Trade Desk Shares Are Soaring, What You Need To Know - TradingView
Is Evolent Health Inc. a good long term investmentExceptional market positioning - jammulinksnews.com
Evolent Health Inc. Stock Analysis and ForecastFree Investment Timing Strategies - jammulinksnews.com
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
Truist Securities Raises Price Target for Evolent Health (EVH) | - GuruFocus
Evolent Health: Truist Securities Maintains Buy, Raises PT to $16 from $14. - AInvest
Evolent Health Insiders Added US$1.35m Of Stock To Their Holdings - 富途牛牛
Evolent Health Announces Q2 Earnings Date and Major Growth Conference Appearance - Stock Titan
Evolent Health, Inc. (NYSE:EVH) Stock Catapults 35% Though Its Price And Business Still Lag The Industry - simplywall.st
Evolent To Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025 - Yahoo Finance
EVH Press Release: Evolent To Release Second Quarter 2025 Financi... - 富途牛牛
Evolent Health taps David Lim as chief clinical officer - MSN
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know - TradingView
BPAS - FinancialContent
Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO By Investing.com - Investing.com South Africa
Evolent Health Appoints Dr. David Lim as Chief Clinical Officer; John Way as CFO, Performance Suite - citybiz
Evolent adds Dr. David Lim as chief clinical officer, John Way as CFO - Investing.com
Former OptumHealth CFO Joins Evolent as Healthcare Giant Expands Specialty Care Leadership - Stock Titan
Evolent Health stock rating reaffirmed at Buy by Truist on managed care trends - Investing.com Canada
The Top 5 Analyst Questions From Evolent Health’s Q1 Earnings Call - Yahoo Finance
SUN extends revolver to 2030, upsizes to $2.46B for Parkland deal | EVH SEC FilingForm 4 - Stock Titan
JMP Maintains Price Target and Market Outperform Rating on Evolent Health (EVH) - Insider Monkey
Evolent Health, Inc.(NYSE: EVH) added to Russell Small Cap Comp Value Index - MarketScreener
Evolent Health Inc (EVH) 財務データ
収益
当期純利益
現金流量
EPS
Evolent Health Inc (EVH) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
McCarthy Daniel Joseph | PRESIDENT |
Mar 06 '25 |
Buy |
9.01 |
11,040 |
99,470 |
389,004 |
Jelinek Richard M | Director |
Mar 07 '25 |
Buy |
9.12 |
30,000 |
273,750 |
15,000 |
GRUA PETER J | Director |
Mar 06 '25 |
Buy |
9.01 |
11,040 |
99,470 |
18,749 |
Blackley Seth | Chief Executive Officer |
Mar 06 '25 |
Buy |
9.01 |
55,225 |
497,577 |
762,217 |
Springstubb Brendan B | Director |
Mar 07 '25 |
Buy |
9.27 |
15,000 |
139,050 |
26,842 |
Glass Russell Monroe | Director |
Mar 06 '25 |
Buy |
9.27 |
5,400 |
50,058 |
14,272 |
KECK KIM | Director |
Mar 07 '25 |
Buy |
9.44 |
10,540 |
99,498 |
39,522 |
Barbarosh Craig A. | Director |
Mar 06 '25 |
Buy |
8.81 |
2,000 |
17,620 |
31,956 |
Springstubb Brendan B | Director |
Mar 04 '25 |
Buy |
8.75 |
5,000 |
43,750 |
11,842 |
大文字化:
|
ボリューム (24 時間):